Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person D'Eustachio, Peter, 2023-06-27
| Class:Id | InstanceEdit:9838903 |
|---|
| _displayName | D'Eustachio, Peter, 2023-06-27 |
|---|
| _timestamp | 2023-06-27 18:33:50 |
|---|
| author | [Person:140934] D'Eustachio, Peter |
|---|
| dateTime | 2023-06-27 18:33:45 |
|---|
| (created) | [InstanceEdit:9838901] D'Eustachio, Peter, 2023-06-27
[ChemicalDrug:9838902] TBM [endoplasmic reticulum lumen]
[StableIdentifier:9838904] R-ALL-9838902.1 |
|---|
| (modified) | [Reaction:211988] CYP2C9 inactivates tolbutamide by 4methyl-hydroxylation [Homo sapiens]
[PathwayDiagram:500339] Diagram of Phase I - Functionalization of compounds, Defective CYP11A1 causes AICSR, Defective CYP11B1 causes AH4, Defective CYP11B2 causes CMO-1 deficiency, Defective CYP19A1 causes AEXS, Defective CYP1B1 causes Glaucoma, Defective CYP21A2 causes AH3, Defective CYP24A1 causes HCAI, Defective CYP26B1 causes RHFCA, Defective CYP26C1 causes FFDD4, Defective CYP2U1 causes SPG56, Defective CYP4F22 causes ARCI5, Defective CYP7B1 causes SPG5A and CBAS3, Defective FMO3 causes TMAU, Defective MAOA causes BRUNS, and Defective TBXAS1 causes GHDD |
|---|
| (structureModified) | [Reaction:211988] CYP2C9 inactivates tolbutamide by 4methyl-hydroxylation [Homo sapiens] |
|---|
|
[Change default viewing format]
|
No pathways have been reviewed or authored by D'Eustachio, Peter, 2023-06-27 (9838903)
